References
- Alhadramy MS. 2016. Diabetes and oral therapies: A review of oral therapies for diabetes mellitus. J Taibah Uni Med Sc. 11(4):317–329. doi:https://doi.org/10.1016/j.tumed.2016.02.001
- Arthur SJ, John B. 1978. A colour Atlas of histopathological staining techniques. London: Wolf Medical Publisher Limited; p. 14–20.
- Aylward G. 2005. Progressive changes in diabetics and their management. Eye. 19(10):1115–1118. doi:https://doi.org/10.1038/sj.eye.6701969
- Baynes HW. 2015. Classification, Pathophysiology, diagnosis and management of Diabetes Mellitus. J Diabetes Metab. 6:541–548. doi:https://doi.org/10.4172/2155-6156.1000541
- Berkels R, Egink G, Marsen TA, Bartels H, Roesen R, Klaus W. 2001. Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanisms. Hyperten. 37:240–245. doi:https://doi.org/10.1161/01.HYP.37.2.240
- Budin SB, Kee KP, Eng MYS, Osman K, Bakar MA, Mohamed J. 2007. Alpha-lipoic acid prevents pancreatic islet cells damage and dyslipidemia in streptozotocin-induced diabetic rats. Malays J Med Sci. 14(2):47–53. doi:https://doi.org/10.22159/ajpcr.2018.v11i2.23241
- Edwards PA, Muroya H, Gould RG. 1972. In vivo demonstration of the circadian rhythm of cholesterol biosynthesis in the liver and intestine of the rat. J Lipid Res. 13:396–401. doi:https://doi.org/10.4172/2155-6156.1000131
- Emara E, Abdel-Sater KA. 2011. Beneficial effects of calcium channel blocker “Nifedipine” on abnormalities of platelets and lipid metabolism in patients with type II diabetes mellitus. J Diabetes Metab. 2(5):131–137. doi:https://doi.org/10.4172/2155-6156.1000131
- Engerman RL, Kern TS. 1984. Experimental galactosemia produces diabetic-like retinopathy. Diabetes. 33:97–100. doi:https://doi.org/10.2337/diab.33.1.97
- Eronmosele J, Olurishe TO, Olorukooba AB. 2020. Investigation of treatment-time differences in colistin-induced nephrotoxicity in Wistar rats. Chronobiol Int. doi:https://doi.org/10.1080/07420528.2020.1838535.
- Finlay LA, Michels AJ, Butler JA, Smith EJ, Monette JS, Moreau RF. 2012. R-α-lipoic acid does not reverse hepatic inflammation of aging, but lowers lipid anabolism, while accentuating circadian rhythm transcript profiles. Am J Physiol Regul Integr Comp Physiol. 302:587–597. doi:https://doi.org/10.1152/ajpregu.00393.2011
- Greene DA, Sima AA, Stevens MJ, Feldman EL, Lattimer SA. 1992. Complications: neuropathy, pathogenetic considerations. Diabetes Care. 15:1902–1925. doi:https://doi.org/10.2337/diacare.15.12.1902
- Halim EM, Ali H. 2002. Reversal of diabetic retinopathy in streptozotocin induced diabetic rats using Indian anti-diabetic plant Azadirachta indica (L). Indian J Clin Biochem. 17(2):115–123. doi:https://doi.org/10.1007/BF02867983
- Hermida RC, Ayala DE, Mojon A, Fernandez JR. 2008. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Am J Hyperten. 21:948–954. doi:https://doi.org/10.1038/ajh.2008.216
- Hussain HE, Jamil K, Mala R. 2001. Hypoglycemic, hypolipidemic and antioxidant properties of Tulsi (Ocimum sanctum Linn) on streptozotocin induced diabetes rats.. Indian J Clin Biochem. 16(2):190–194. doi:https://doi.org/10.1007/BF02864859
- Ishrat K, Jaweed SA, Bardapurkar JS, Patil VP. 2004. Study of magnesium, glycosylated haemoglobin and lipid profile in diabetic retinopathy. Indian J Clin Biochem. 19(2):124–127. doi:https://doi.org/10.1007/BF02894270
- Kaushal R, Dave KR, Katyare SS. 1999. Paracetamol hepatotoxicity and microsomal function. Environ Toxicol Pharmacol. 1:67–74. doi:https://doi.org/10.1016/S1382-6689(98)00053-2
- King H, Aubert RE, Herman WH. 1998. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 21(9):1414–1431. doi:https://doi.org/10.2337/diacare.21.9.1414
- Mak IT, Boehme P, Weqlicki WB. 1992. Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Correlation of protection with preservation of glutathione levels. Circ Res. 70(6):1099–1103. doi:https://doi.org/10.1161/01.RES.70.6.1099
- Manoharan S, Kolanjiappan K. 2005. Diurnal rhythmicity of thiobarbituric acid reactive substances and antioxidants in experimental mammary carcinogenesis. Exp Oncol. 27(4):298–302.
- Nadler JL, Buchanan T, Natrajan R. 1993. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hyperten. 21:1024–1029. doi:https://doi.org/10.1161/01.HYP.21.6.1024
- Obrosova IG, Minchenko AG, Marinescu V, Fathallah L, Kennedy A, Stockert CM, Frank RN, Stevens MJ. 2001. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin diabetic rats. Diabetologia. 44:1102–1110. doi:https://doi.org/10.1007/s001250100631
- Portaluppi F, Smolensky MH, Touitou Y. 2010. Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911–1929. doi:https://doi.org/10.3109/07420528.2010.516381
- Rafieian-Kopaei M, Rahimi-Madiseh M, Malekpour-Tehrani A, Bahmani M. 2016. The research and development on the antioxidants in prevention of diabetic complications. Asian Pac J Trop Med. 9(9):825–831. doi:https://doi.org/10.1016/j.apjtm.2016.07.001
- Ravi K, Rajasekaran S, Subramanium S. 2005. Antihyperlipidemic effect of Eugenia jambolana seed kernel on streptozotocin-induced diabetes in rats. Food Chem Toxicol. 43:1433–1439. doi:https://doi.org/10.1016/j.fct.2005.04.004
- Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. 2001. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev. 17:189–212. doi:https://doi.org/10.1002/dmrr.196
- Safi SZ, Qvist R, Batumalaise K, Ismail IS. 2014. Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. Biomed Res Int. 801269. doi:https://doi.org/10.115/2014/801269
- Sani M, Sebai H, Ghanem-Boughanmi N, Boughattas NA, Mossadok B. 2015. Circadian (about 24-hour) variation in malondialdehyde content and catalase activity of mouse erythrocytes. Redox Rep. 20(1):26–32. doi:https://doi.org/10.1179/1351000214Y.0000000102
- Shapiro DJ, Rodwell VW. 1969. Diurnal variation and cholesterol regulation of hepatic HMG-CoA reductase activity. Biochem Biophys Res Comm. 37:867–872. doi:https://doi.org/10.1016/0006-291X(69)90972-3
- Singh U, Jialal I. 2008. Alpha-lipoic acid supplementation and diabetes. Nutr Rev. 66:646–657. doi:https://doi.org/10.1111/j.1753-4887.2008.00118.x
- Toyohiko Y, Junya A, Yukiyoshi N, Fumihiro S, Kazuma I, Masamichi Y, Midori M, Yutaka K, Yoshiaki T, Hiroya M, et al. 2014. Comparison between two calcium antagonists: blood pressure reduction and renal effects in hypertensive patients with type 2 diabetes. Immunol Endocr Metab Agents Med Chem. 12(2):152–159. doi:https://doi.org/10.2174/187152212800389003